DNA methylation markers for sensitive detection of circulating tumor DNA in patients with gastroesophageal cancers
This study demonstrates that TriMeth may hold potential as a biomarker for identifying ctDNA in patients with G-GEJ ACs. The study sets the scene for ongoing larger clinical studies investigating the performance of TriMeth in different clinical settings.
Authors
- Emilie Marie Niebuhr Aagaard
- Sarah Østrup Jensen (ORCID: https://orcid.org/0000-0001-6044-3362)
- Nadia Øgaard (ORCID: https://orcid.org/0000-0003-0343-8369)
- Charles R. Iden
- Kristoffer Staal Rohrberg (ORCID: https://orcid.org/0000-0002-5448-9003)
- Shuhaimi Mustafa (ORCID: https://orcid.org/0000-0003-1474-998X)
- Claus L. Andersen (ORCID: https://orcid.org/0000-0002-7406-2103)
- Jesper B. Bramsen (ORCID: https://orcid.org/0000-0002-2084-0336)
- Morten Mau‐Sørensen (ORCID: https://orcid.org/0000-0003-2235-1250)
- L.B. Ahlborn
- Jane Preuss Hasselby (ORCID: https://orcid.org/0000-0001-9153-0100)
- Michael Patrick Achiam (ORCID: https://orcid.org/0000-0002-3062-5138)
Institutions
- Aarhus University Hospital (DK)
- Copenhagen University Hospital (DK)
- Rigshospitalet (DK)
Publication Details
- Journal
- ESMO Gastrointestinal Oncology
- Published
- 2024-10-16
- DOI
- https://doi.org/10.1016/j.esmogo.2024.100104
- Citations
- 1
- Primary Topic
- Cancer Genomics and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 0.29
Funders
- Aarhus Universitet
- Cancer Research UK
- Gentofte Hospital
- Novo Nordisk Fonden